ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
Jonathan A. Ledermann(Cancer Institute (WIA)), Anna Fagotti(Agostino Gemelli University Polyclinic), Christina Fotopoulou(Ovarian Cancer Action), Antonio González-Martı́n(MD Anderson Cancer Center Madrid), W. Glenn McCluggage(Belfast Health and Social Care Trust), Charlie Gourley, Frederik Marmé(National Center for Tumor Diseases), Florence Joly(Centre François Baclesse), D. Fischerová(Charles University), Frédéric Amant(KU Leuven), Alexandra Léary, Nicole Concin(Innsbruck Medical University), Giovanni Scambia(Agostino Gemelli University Polyclinic), Sabrina Croce(Institut Bergonié), Christian Marth(Nordic Society of Gynecologic Oncology), Ane Gerda Zahl Eriksson(Memorial Sloan Kettering Cancer Center), Philippe Morice(Université Paris-Sud), Sudha Sundar(University of Birmingham), Ronnie Shapira‐Frommer(Sheba Medical Center), Ignace Vergote(KU Leuven), David S.P. Tan(National University of Singapore), Ignacio Romero(Fundación Instituto Valenciano de Oncología), Luis Chiva(Clinica Universidad de Navarra), Domenica Lorusso(Agostino Gemelli University Polyclinic), Pedro T. Ramírez(The University of Texas MD Anderson Cancer Center), José Alejandro Pérez Fidalgo(INCLIVA Health Research Institute), Susana Banerjee(Royal Marsden NHS Foundation Trust), Ana Oaknin(Vall d'Hebron Institute of Oncology), Xavier Matías‐Guiu(Instituto de Investigación Biomédica de Lleida), Conxi Lázaro(Institut d'Investigació Biomédica de Bellvitge), Shibani Nicum(Cancer Institute (WIA)), David Cibula(Prague University of Economics and Business), Isabelle Ray‐Coquard(Centre Léon Bérard), Claire Falandry(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Ben Davidson(Oslo University Hospital), Philipp Harter, Sandro Pignata(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Cristiana Sessa(Université Claude Bernard Lyon 1), François Planchamp, Iain A. McNeish, Çağatay Taşkıran(Koç University), Sven� Mahner(Universität Hamburg), Nicoletta Colombo(University of Milan), Willemien J. van Driel(Gynecologic Oncology Group), C.A.R. Lok(The Netherlands Cancer Institute), Jalid Sehouli
Cited by 277
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
|International Journal of Gynecological Cancer|2020|1.9k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k